Assembly Biosciences, Inc. (ASMB)
34.07
-0.73
(-2.10%)
USD |
NASDAQ |
Aug 28, 16:00
34.00
-0.07
(-0.21%)
After-Hours: 20:00
Assembly Biosciences Profit Margin (Quarterly) : -28.84% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -28.84% |
| March 31, 2026 | -110.5% |
| December 31, 2025 | 52.01% |
| September 30, 2025 | -85.24% |
| June 30, 2025 | -105.9% |
| March 31, 2025 | -93.62% |
| December 31, 2024 | -140.5% |
| September 30, 2024 | -140.4% |
| June 30, 2024 | -130.7% |
| March 31, 2024 | -156.9% |
| December 31, 2023 | -153.0% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 |
| Date | Value |
|---|---|
| September 30, 2021 | -300.7% |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -3.80K% |
| September 30, 2020 | -9.68% |
| June 30, 2020 | 18.46% |
| March 31, 2020 | -653.1% |
| December 31, 2019 | -568.3% |
| September 30, 2019 | -590.8% |
| June 30, 2019 | -600.7% |
| March 31, 2019 | -696.3% |
| December 31, 2018 | -700.4% |
| September 30, 2018 | -502.5% |
| June 30, 2018 | -833.0% |
| March 31, 2018 | -455.8% |
| December 31, 2017 | -90.70% |
| September 30, 2017 | -461.4% |
| June 30, 2017 | -576.4% |
| March 31, 2017 | -2.04K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | -134.2% |
| BridgeBio Pharma, Inc. | -63.97% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -0.02% |
| Return on Assets | -0.02% |
| Return on Invested Capital | -0.02% |
| Gross Profit Margin (Quarterly) | 99.85% |
| Operating Margin (Quarterly) | -47.44% |
| Return on Net Operating Assets | -1.24% |